These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2613707)

  • 1. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine.
    Klockmann U; Bock HL; Franke V; Hein B; Reiner G; Hilfenhaus J
    J Biol Stand; 1989 Oct; 17(4):331-42. PubMed ID: 2613707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain.
    Gresíková M; Sekeyová M; Marcinka K; Ciampor F
    Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines].
    Vorob'eva MS; Rasshchepkina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):35-7. PubMed ID: 1301660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose vaccine against tick-borne encephalitis.
    Rumyantsev AA; Goncalvez AP; Giel-Moloney M; Catalan J; Liu Y; Gao QS; Almond J; Kleanthous H; Pugachev KV
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13103-8. PubMed ID: 23858441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.
    Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG
    PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
    Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation].
    El'bert LB; Gagarina AV; Khanina MK; Krutianskaia GL; Grachev VP
    Vopr Virusol; 1980; (3):341-5. PubMed ID: 7434727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures].
    El'bert LB; Vorovich MF; Terletskaia EN; Lisitsina EA; Atanadze SN; Sidorovich IG; Khozinskiĭ VV; Tugizov ShM; Kushch AA; Khapchaev IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):25-8. PubMed ID: 1414102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.
    Kunz C; Heinz FX; Hofmann H
    J Med Virol; 1980; 6(2):103-9. PubMed ID: 7241091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study.
    Bock HL; Klockmann U; Jüngst C; Schindel-Künzel F; Theobald K; Zerban R
    Vaccine; 1990 Feb; 8(1):22-4. PubMed ID: 2316281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine.
    Hopf S; Garner-Spitzer E; Hofer M; Kundi M; Wiedermann U
    Vaccine; 2016 Apr; 34(17):2027-34. PubMed ID: 26768126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory].
    Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.